These high and significant AUC performances suggested that both YY1 and BCL2L15 expression levels can be considered as diagnostic discriminators between primary—less aggressive, and metastasis—more aggressive, subgroups in CRC-affected subjects. Here, BCL2L15 is linked to colorectal carcinoma.